BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17951127)

  • 1. Tolerogenic dendritic cells in health and disease: friend and foe!
    Adler HS; Steinbrink K
    Eur J Dermatol; 2007; 17(6):476-91. PubMed ID: 17951127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
    Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
    Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation.
    Puccetti P; Grohmann U
    Nat Rev Immunol; 2007 Oct; 7(10):817-23. PubMed ID: 17767193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
    Delgado M; Gonzalez-Rey E; Ganea D
    Ann N Y Acad Sci; 2006 Jul; 1070():233-8. PubMed ID: 16888172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
    Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
    Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase.
    Gillet-Hladky S; de Carvalho CM; Bernaud J; Bendahou C; Bloy C; Rigal D
    Transplantation; 2006 Oct; 82(7):965-74. PubMed ID: 17038913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
    Vlad G; Chang CC; Colovai AI; Berloco P; Cortesini R; Suciu-Foca N
    Hum Immunol; 2009 May; 70(5):340-4. PubMed ID: 19275918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory role of dendritic cells in the immune tolerance.
    Li YP; Latger-Canard V; Marchal L; Li N; Ou-Yang JP; Stoltz JF
    Biomed Mater Eng; 2006; 16(4 Suppl):S163-70. PubMed ID: 16823108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells.
    Volchenkov R; Karlsen M; Jonsson R; Appel S
    Scand J Immunol; 2013 Apr; 77(4):246-54. PubMed ID: 23442246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory dendritic cell therapy in organ transplantation.
    McCurry KR; Colvin BL; Zahorchak AF; Thomson AW
    Transpl Int; 2006 Jul; 19(7):525-38. PubMed ID: 16764631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4.
    Chang CC; Ciubotariu R; Manavalan JS; Yuan J; Colovai AI; Piazza F; Lederman S; Colonna M; Cortesini R; Dalla-Favera R; Suciu-Foca N
    Nat Immunol; 2002 Mar; 3(3):237-43. PubMed ID: 11875462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity.
    Torres-Aguilar H; Blank M; Jara LJ; Shoenfeld Y
    Autoimmun Rev; 2010 Nov; 10(1):8-17. PubMed ID: 20678591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.